Genocea teams with military on malaria vax research

With the help of a $2.7 million grant from the U.S. Army Medical Research and Materiel Command, Genocea Biosciences will collaborate with the Naval Medical Research Center to identify antigens that will be used to develop a vaccine candidate against Plasmodium falciparum for the prevention of malaria. Genocea release

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.